Evaluation of ovarian reserve, aging and fertility preservation in women with sickle cell disease
Evaluation of ovarian reserve, aging and fertility preservation in women with sickle cell disease
批准号:
10217221
负责人:
Bo Yu
金额:
$23.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-01 至 2024-06-30
关键词:
AccelerationAcuteAddressAdultAdverse eventAffectAfricanAfrican AmericanAgeAgingAssisted Reproductive TechnologyBiologicalBirthCaringCellsChildChildhoodChronicChronic DiseaseClinicalClinical ResearchCollaborationsCounselingCryopreservationDNA MethylationDataDiseaseEligibility DeterminationEmbryoErythrocyte TransfusionEvaluationFemaleFemale AdolescentsFertilityFollicular FluidFoundationsFunctional disorderFutureGene ExpressionGoalsGrantHeadHealthHealth PersonnelHematological DiseaseHematologistHypoxiaImmunizationImpairmentInfertilityInflammationInflammatoryInterventionInvestigationKnowledgeLifeMeasuresMendelian disorderMethodsModalityMolecularMorbidity - disease rateNeonatal ScreeningObservational StudyOocytesOrganOutcomeOvarianOvarian Granulosa CellOvarian agingPathologyPatientsPenicillinsPhysiologyPilot ProjectsPopulationProceduresProphylactic treatmentProtocols documentationRecommendationRecurrenceRegistriesReproductionReproductive EndocrinologyReproductive HealthResearch PersonnelRiskSeverity of illnessSickle Cell AnemiaSolidSpecialistStreptococcus pneumoniaeTestingTherapeuticTimeTissuesUnited StatesUniversitiesWashingtonWomanWorkage relatedagedbasecohortdiminished ovarian reservedisorder controlembryo cryopreservationfemale fertilityfertility preservationgranulosa cellhigh riskhydroxyureaimprovedinsightmale fertilityoffspringoocyte cryopreservationovarian reserveprogramsreproductivesafety studysubfertilitysuccesstreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Sickle cell disease (SCD) is one of the most common monogenic diseases affecting over 300,000 births
worldwide and 1 in 400 of African descent. In the last few decades, SCD has evolved from a life-threatening
disease of childhood to a chronic disease in adults. With improved survival and reduced disease-related
morbidity, reproductive health is emerging as a priority in SCD care. However, appropriate fertility counseling
and treatment recommendations are limited by our lack of understanding of the impact of SCD and disease-
modifying therapies on reproduction. There is an urgent need to evaluate the fertility and to optimize fertility
preservation options in women affected by SCD. The objectives of this proposal are to evaluate how SCD
affects ovarian reserve and female fertility, and to determine what the best timing and methods to preserve
fertility are in these women. The central hypothesis is that SCD leads to accelerated ovarian aging through
chronic tissue hypoxia and inflammation, which adversely affects the fertility of women with SCD. Utilizing our
complementary expertise and an existing adult SCD clinical research program, we propose the following
studies to achieve our objectives: Aim 1. Measure ovarian reserve in adult women with SCD and follow
longitudinally over two years. Aim 2. Establish optimal fertility preservation protocol in a pilot cohort of women
with SCD and optimize the management of any adverse events that occur during their assisted reproductive
treatments. Aim 3. Assess ovarian aging acceleration and inflammation in the ovarian granulosa cells obtained
from women with SCD, as compared with age-matched non-SCD controls. These studies will the first to
systematically evaluate the impact of SCD on ovarian aging and female fertility from both clinical and molecular
levels. This work will significantly improve our ability to counsel women with SCD on their risks of infertility and
how these risks are modified by age and disease severity. This grant will lay important groundwork for a more
comprehensive study on ovarian pathophysiology in adolescent females with SCD, with the goal of optimizing
fertility preservation prior to onset of end-organ damage in this younger population. The preliminary data
obtained from this study will also serve as the basis for establishing a national registry to surveil fertility
preservation approaches and long-term outcomes in women with SCD seeking fertility evaluation and
treatments. These investigations will increase our understanding of how SCD impacts female fertility and serve
the unmet reproductive health needs of all women with SCD.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Preconception paternal comorbidities and offspring birth defects: Analysis of a large national data set.
孕前父亲合并症和后代出生缺陷:大型国家数据集的分析。
DOI:
10.1002/bdr2.2082
发表时间:
2023
期刊:
Birth defects research
影响因子:
2.1
作者:
[Yu,Bo, Zhang,ChiyuanAmy, Li,Shufeng, Chen,Tony, Mulloy,Evan, Shaw,GaryM, Eisenberg,MichaelL]
通讯作者:
Eisenberg,MichaelL
The role of fallopian tube microbiome in ovarian carcinogenesis
-
批准号:10663005
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2023
-
负责人:Bo Yu
-
依托单位:
Evaluation of ovarian reserve, aging and fertility preservation in women with sickle cell disease
-
批准号:10307488
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2021
-
负责人:Bo Yu
-
依托单位:
Regulation of Alveolar Bone Marrow MSC Senescence in Skeletal Aging and Periodontitis
-
批准号:10186006
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2021
-
负责人:Bo Yu
-
依托单位:
Regulation of Alveolar Bone Marrow MSC Senescence in Skeletal Aging and Periodontitis
-
批准号:10621947
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2021
-
负责人:Bo Yu
-
依托单位:
Regulation of Alveolar Bone Marrow MSC Senescence in Skeletal Aging and Periodontitis
-
批准号:10443711
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2021
-
负责人:Bo Yu
-
依托单位:
The role of fallopian tube microbiome in ovarian carcinogenesis
-
批准号:10300334
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2018
-
负责人:Bo Yu
-
依托单位:
The role of fallopian tube microbiome in ovarian carcinogenesis
-
批准号:10355543
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2018
-
负责人:Bo Yu
-
依托单位:
海外基金